Search results for: 'pi3 kinase p110'
-
BA6330 LazertinibSummary: A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor. - BA6495 MMI-0100Summary: MMI-0100 is a cell-permeable peptide inhibitor that inhibits mitogen-activated protein kinase-activated protein kinase II.
- BA3283 HG-7-85-01Summary: HG-7-85-01 inhibits the T315I mutant kinase with little or no inhibition of other kinases (IC>2 μM).
- BA3848 MFH290Summary: MFH290 is a potent and highly selective covalent inhibitor of cell cycle protein-dependent kinase 12/13.
- BA8864 BezuclastinibSummary: Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent anti-activity.
- BA8876 ZongertinibSummary: Zongertinib (BI1810631) is a potent, selective and tyrosine kinase inhibitor with values of 13nM and 579nM, respectively.
- BA8913 BT173Summary: BT173 is a potent homologous structural domain interacting protein kinase 2 (HIPK2) inhibitor.
- BA9119 TDI-011536Summary: TDI-011536 is a potent kinase inhibitor that interrupts signaling and may initiate proliferation of damaged cardiomyocytes.
- BA9153 IN-1130Summary: N-1130 is a highly selective inhibitor of transforming growth factor-beta type I receptor kinase.
- BA4969 MalantideSummary: Malantide is a synthetic dodecapeptide derived from a site that is phosphorylated on the beta subunit of phosphorylase kinase.